4.7 Article

The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation

期刊

BLOOD
卷 121, 期 17, 页码 3386-3395

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-11-468868

关键词

-

资金

  1. National Institutes of Health [R01HL089745]
  2. XLP Research Trust
  3. Alex's Lemonade Stand Foundation
  4. Canadian Institutes of Health Research

向作者/读者索取更多资源

The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) plays critical roles during invariant natural killer T (iNKT) cell ontogeny. As a result, SAP-deficient humans and mice lack iNKT cells. The strict developmental requirement for SAP has made it difficult to discern its possible involvement in mature iNKT cell functions. By using temporal Cre recombinase-mediated gene deletion to ablate SAP expression after completion of iNKT cell development, we demonstrate that SAP is essential for T-cell receptor (TCR)-induced iNKT cell cytotoxicity against T-cell and B-cell leukemia targets in vitro and iNKT-cell-mediated control of T-cell leukemia growth in vivo. These findings are not restricted to the murine system: silencing RNA-mediated suppression of SAP expression in human iNKT cells also significantly impairs TCR-induced cytolysis. Mechanistic studies reveal that iNKT cell killing requires the tyrosine kinase Fyn, a known SAP-binding protein. Furthermore, SAP expression is required within iNKT cells to facilitate their interaction with T-cell targets and induce reorientation of the microtubule-organizing center to the immunologic synapse (IS). Collectively, these studies highlight a novel and essential role for SAP during iNKT cell cytotoxicity and formation of a functional IS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Pediatrics

The american pediatric society and society for pediatric research joint statement against racism and social injustice

Steven H. Abman, Sarah Armstrong, Susan Baker, Clifford W. Bogue, Waldemar Carlo, Lina Chalak, Stephen R. Daniels, Stephanie Davis, Michael R. Debaun, Candice Fike, Lauren Frazer, Keisha Gibson, Michelle Gill, Hannah Glass, Catherine M. Gordon, Monika Goyal, Joel Hirschhorn, Lori Holtz, David Hunstad, Mary B. Leonard, Nathalie Maitre, Larry Markham, Linda McAllister-Lucas, Jordan Orange, Prachi Shah, Tamar Simon, Robin H. Steinhorn, Beth Tarini, Leslie R. Walker-Harding

PEDIATRIC RESEARCH (2022)

Article Rheumatology

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2

Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, Mark Gorelik, Sivia K. Lapidus, Hamid Bassiri, Edward M. Behrens, Anne Ferris, Kate F. Kernan, Grant S. Schulert, Philip Seo, Mary Beth F. Son, Adriana H. Tremoulet, Rae S. M. Yeung, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay J. Mehta

Summary: This article provides guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS-C) and hyperinflammation in children with coronavirus disease 2019 (COVID-19). A multidisciplinary Task Force developed 40 guidance statements and a flow diagram for the diagnostic pathway of MIS-C.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Immunology

Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis

Stephanie J. Si, Sarah K. Tasian, Hamid Bassiri, Brian T. Fisher, Jasmyn Atalla, Reema Patel, Neil Romberg, Michele P. Lambert, Michele Paessler, Edward J. Behrens, David T. Teachey, Kathleen E. Sullivan

Summary: HLH is a syndrome of severe immune dysregulation with a complex diagnosis process, leading to potential delays in treatment initiation.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Rheumatology

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3

Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, Mark Gorelik, Sivia K. Lapidus, Hamid Bassiri, Edward M. Behrens, Kate F. Kernan, Grant S. Schulert, Philip Seo, Mary Beth F. Son, Adriana H. Tremoulet, Christina VanderPluym, Rae S. M. Yeung, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay J. Mehta

Summary: This study provides guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS-C) and hyperinflammation during COVID-19. The guidance was developed through expert consensus and includes 41 guidance statements and flow diagrams for the diagnosis and initial treatment of MIS-C.

ARTHRITIS & RHEUMATOLOGY (2022)

Letter Hematology

Development of BRAFV600E-positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH

Marta Salek, Ninad Oak, Melissa Hines, Jamie L. Maciaszek, Ruth Tatevossian, Akshay Sharma, Kim E. Nichols, Patrick Campbell

BLOOD ADVANCES (2022)

Article Oncology

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Caroline Diorio, Rawan Shraim, Regina Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M. DiNofia, Saar Gill, Vanessa Gonzalez, Michele P. Lambert, Allison Barz Leahy, Bruce L. Levine, Robert B. Lindell, Shannon L. Maude, J. Joseph Melenhorst, Haley Newman, Jessica Perazzelli, Alix E. Seif, Simon F. Lacey, Carl H. June, David M. Barrett, Stephan A. Grupp, David T. Teachey

Summary: In this study, we used proteomic profiling to identify predictive biomarkers for severe CRS and found that IFN gamma pathway plays a fundamental role in driving CRS. We also identified a potentially targetable cytokine associated with ICANS. These findings have important implications for disease treatment.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition

Suzanne P. MacFarland, Luke Maese, Surya P. Rednam, Junne Kamihara, Melissa R. Perrino, Kim E. Nichols, Garrett M. Brodeur, Joshua D. Schiffman, Sharon E. Plon, Lisa R. Diller, David Malkin, Christopher C. Porter, Anita Villani

Summary: Germline pathogenic variants are frequently found in children with cancer. Due to the rarity and underrecognition of pediatric cancer predisposition syndromes, a new consortium has been established to optimize care and advance research in this area.

CANCER PREVENTION RESEARCH (2022)

Article Genetics & Heredity

Germline pathogenic SMARCA4 variants in neuroblastoma

Leora Witkowski, Kim E. Nichols, Marjolijn Jongmans, Nienke van Engelen, Ronald R. de Krijger, Jennifer Herrera-Mullar, Lieve Tytgat, Armita Bahrami, Helen Mar Fan, Aimee L. Davidson, Thomas Robertson, Michael Anderson, Martin Hasselblatt, Sharon E. Plon, William D. Foulkes

Summary: Heterozygous germline pathogenic variants in the SMARCA4 gene can predispose to several rare tumour types, including neuroblastoma. These findings suggest that neuroblastoma should be included in the spectrum of SMARCA4-associated tumours.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Germline genomic findings in children and young adults with melanocytic tumors

Margaret B. B. Nagel, Melissa R. R. Perrino, Regina Nuccio, Alise K. K. Blake, Lynn Harrison, Kim E. E. Nichols, Alberto S. S. Pappo

Summary: In this retrospective study, the prevalence and spectrum of germline variants in cancer predisposition genes were examined in 38 children and young adults with melanocytic lesions at St. Jude Children's Research Hospital. The study found that 15.8% of patients had pathogenic germline variants, including various genetic mutations in genes such as PMS2, TP53, BRIP1, ATM, and AXIN2.

PEDIATRIC BLOOD & CANCER (2023)

Editorial Material Hematology

Deciphering genetic uncertainty in familial HLH

Lauren K. Meyer, Kim E. Nichols

Summary: In this article, the authors present a novel in vitro approach to study germline variants in genes associated with familial hemophagocytic lymphohistiocytosis (fHLH). This method enables the analysis of variants of uncertain significance (VUS) and provides insights into their functional consequences.
Letter Hematology

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

Matthew R. Schuelke, Hamid Bassiri, Edward M. Behrens, Scott Canna, Colleen Croy, Amanda DiNofia, Kandace Gollomp, Stephan Grupp, Michele Lambert, Arathi Lambrix, Shannon L. Maude, Regina Myers, Haley Newman, Whitney Petrosa, Alix Seif, Kathleen E. Sullivan, David T. Teachey, Caroline Diorio

BLOOD ADVANCES (2023)

Article Oncology

Parental Preferences Surrounding Timing and Content of Consent Conversations for Clinical Germline Genetic Testing Following a Child's New Cancer Diagnosis

Belinda N. Mandrell, Liza Marie Johnson, Mary Caples, Jami Gattuso, Jamie L. Maciaszek, Roya Mostafavi, Katianne M. Howard Sharp, Kim E. Nichols

Summary: This study aimed to understand parent preferences regarding the timing and content of consent conversations for clinical germline genetic testing of children with cancer. The survey results revealed that most parents preferred consent conversations to take place one month after the cancer diagnosis and desired testing of as many cancer-related genes as possible.

JCO PRECISION ONCOLOGY (2022)

Article Oncology

Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells

Yao-Yu Gong, Hongguang Shao, Yu Li, Patricia Brafford, Zachary E. Stine, Jing Sun, Dean W. Felsher, Jordan S. Orange, Steven M. Albelda, Chi Dang

Summary: This study demonstrates the feasibility of metabolic engineering immune effector cells to overcome inhibition in the tumor microenvironment, an approach that could enhance the efficacy of adoptive transfer immunotherapy.

CANCER RESEARCH COMMUNICATIONS (2022)

Article Psychology, Clinical

Case Series: Neurobehavioral Profile of Adolescents with PTEN Hamartoma Tumor Syndrome

Holly M. Hasler, Alise Murray, Kristin E. Canavera, Kendra R. Parris, Kim E. Nichols, Lisa M. Jacola

Summary: This study found that individuals with PTEN hamartoma tumor syndrome (PHTS) commonly experience cognitive difficulties, including borderline to average global intellectual functioning and deficits in non-verbal reasoning, visual-motor integration, math achievement, and adaptive skills. Therefore, routine neurocognitive assessment should be considered in the management of PHTS patients.

JOURNAL OF PEDIATRIC NEUROPSYCHOLOGY (2022)

Article Hematology

CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies

Yixin Hu, Kenneth J. Caldwell, Mihaela Onciu, Sara M. Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E. Nichols, Clifford M. Takemoto, Brandon M. Triplett, Jason E. Farrar, Jeffrey E. Rubnitz, Raul C. Ribeiro, Marcin W. Wlodarski

Summary: CP X-351, a fixed ratio of liposomal cytarabine to daunorubicin, is effective and well-tolerated in pediatric sMDS/AML patients, showing complete morphologic remission without significant toxicity. Prospective studies are warranted to further evaluate its potential in this population.

BLOOD ADVANCES (2022)

暂无数据